I looked at some articles last night on Genesense. It has a strong support among doctors. Remember it failed 7 vs 3 on the Oncology Panel. Amazingly the panel consisted of non oncology specialists. So, there is some hope. I think it will be rejected again but there will be some new like a co branding with Pfizer or someone else. However, I think you are on the right track with this new drug. The problem is that this company needs some better pipeline or else it goes under in a year.
My comment was not due to the presentation only, IMHO the stimulus bill is going to the senate next week and after back & forth to congress/senate the final approval will come on the weekend of 7th & 8th. After senate approval the market will catch fire and top of that any good news on that week this stock will sky rocket , GLTA